Skip to content
Erudio Health
menu
Clinical trial · no report yet · Phase 3

Sindas

Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)

We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.

Preliminary discovery

Commentary in our index that names this trial so far

Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.

ChannelFound
X threads38
YouTube3
Podcasts1

The trial

ClinicalTrials.gov
Official title
Tyrosine-kinase Inhibitor (TKI) With or Without SBRT in Newly Diagnosed EGFRm Advanced Staged Lung Adenocarcinoma
Phase
Phase 3
Status
Terminated
Conditions
Stage IV EGFR Mutated Non-Small Cell Lung Cancer
Interventions
Radiation: SBRT; TKI (Gefitinib or Tarceva )
Arms
  • TKI without SBRT · Active comparator
  • TKI with SBRT · Experimental
Enrollment
200 (estimated)
Primary outcomes
  • Progression free survival
Sponsor
Sichuan Provincial People's Hospital
Start
Jan 15, 2016
Primary completion
Aug 30, 2020
Results posted
No
Registry record
NCT02893332 · updated Feb 3, 2021

Publications

linked from the registry
  • Wang XS, Bai YF, Verma V, Yu RL, Tian W, Ao R, Deng Y, Zhu XQ, Liu H, Pan HX, Yang L, Bai HS, Luo X, Guo Y, Zhou MX, Sun YM, Zhang ZC, Li SM, Cheng X, Tan BX, Han LF, Liu YY, Zhang K, Zeng FX, Jia L, Hao XB, Wang YY, Feng G, Xie K, Lu Y, Zeng M. Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer. J Natl Cancer Inst. 2023 Jun 8;115(6):742-748. doi: 10.1093/jnci/djac015. PubMed 35094066